November 2021 FDA Recall Drug by Sandoz Inc
D-0286-2022 - Temperature Abuse; temperature excursion during shipping

This Class I drug recall was voluntarily initiated by Sandoz Inc on November 17, 2021 for the product Drug. The FDA reported the reason for recall as temperature abuse; temperature excursion during shipping. The product was distributed Nationwide and the recall is currently completed.

Recall Number: D-0286-2022

Reason for Recall
Temperature Abuse; temperature excursion during shipping
Initiated
11-17-2021
Reported
12-08-2021
Quantity
45,036 cartons

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Nationwide in the US
Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Rx Only; 0.4 mL Syringes, Manufactured for Sandoz Inc., Princeton, NJ 08540, NDC 00781-3246-02; Carton (10 x 0.4 mL Syringes), Manufactured by Shenzhen Techdow Pharmaceutical Co., Ltd. Shenzhen City, Guangdong Province 518057, China for Sandoz Inc., Princeton, NJ 08540, NDC 00781-3246-64

Batch or Lot Expiration Information

Lot# SAB06761A, exp 04/2023